Pharmamarketeer
onderzoek

Bristol-Myers misses main goal of late-stage skin cancer trial

21 november 2019
Reuters Health

late-stage skin cancer trial

Bristol-Myers Squibb Co said on Wednesday its late-stage trial testing a combination of its cancer drugs missed a main goal of preventing skin cancer from recurring in a certain group of patients.

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)